# A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers

> **NCT01860508** · NA · UNKNOWN · sponsor: **Fudan University** · enrollment: 94 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** pemetrexed /carboplatin

## Key facts

- **NCT ID:** NCT01860508
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2014-02
- **Final completion:** —
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2013-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01860508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01860508, "A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01860508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*